Jean-Jacques Bienaim
2006
In 2006, Jean-Jacques Bienaim earned a total compensation of $2.6M as Chief Executive Officer at BioMarin Pharmaceutical.
Compensation breakdown
| Non-Equity Incentive Plan | $662,458 |
|---|---|
| Option Awards | $1,362,931 |
| Salary | $552,393 |
| Other | $22,892 |
| Total | $2,600,674 |
Bienaim received $1.4M in option awards, accounting for 52% of the total pay in 2006.
Bienaim also received $662.5K in non-equity incentive plan, $552.4K in salary and $22.9K in other compensation.
Rankings
In 2006, Jean-Jacques Bienaim's compensation ranked 1,310th out of 7,022 executives tracked by ExecPay. In other words, Bienaim earned more than 81.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,310 out of 7,022 | 81st |
Division Manufacturing | 407 out of 2,413 | 83rd |
Major group Chemicals And Allied Products | 67 out of 673 | 90th |
Industry group Drugs | 34 out of 518 | 93rd |
Industry Pharmaceutical Preparations | 29 out of 355 | 92nd |
Source: SEC filing on April 30, 2007.
Bienaim's colleagues
We found four more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2006.
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019